Program
Inhaled fentanyl aerosol
Also written as “Inhaled Fentanyl Aerosol”.
Its studies are mostly in Cancer Pain · Neoplasms, led by Lee's Pharmaceutical.
Furthest: phase 2, since Jan 13, 20213 company-led studies, 1 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Lee's Pharmaceutical | 31 open or running | phase 2since Jan 13, 2021 | Jan 13, 2021 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jan 13, 2021First study: phase 2 study in Breakthrough Cancer PainFirst studyNCT04713189 · 96 enrolled
- Sep 4, 2022Phase 2 study in Breakthrough Cancer PainNCT05531422 · 60 enrolled · China
- Apr 16, 2025Phase 1 study in NeoplasmsNCT06953453 · 100 planned · China
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06953453Neoplasms · China | 1 | Recruiting | Jul 20, 2026 | 100 |
| NCT05531422Breakthrough Cancer Pain · China | 2 | Completed | Mar 15, 2023 | 60 |
| NCT04713189Breakthrough Cancer Pain | 2 | UNKNOWN | Dec 21, 2021 | 96 |
How it is read
Names in the registry
- “Inhaled fentanyl aerosol”, 2 entries
- “Inhaled Fentanyl Aerosol”, 1 entry
Conditions, from the studies’ own filings
- Cancer Pain, 2 studies
- Neoplasms, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.